Valeant to Buy Medicis Pharmaceutical For $2.6B

Valeant Pharmaceuticals International, Inc. said it agreed to buy Medicis Pharmaceutical Corp. in a transaction valued at about $2.6 billion.

Climate Change Costs Mount: How Markets Are Impacted
23:01 - Bank of America Merrill Lynch thematic investing strategy head Sarbjit Nahal discusses climate change’s risk to portfolios with Bloomberg's Joe Weisenthal and Alix Steel on "What'd You Miss?" (Source: Bloomberg)
  • Industries Where Robots Are Taking Over
  • Are Emerging Markets Set for a Comeback?
  • What's Happening in the Currency Market?